Association of hyperuricemia and serum uric acid lowering therapy with mortality in hemodialysis patients.

Introduction: In the general population, hyperuricemia is associated with increased morbidity and mortality. Data on this association in hemodialysis patients is controversial. Moreover, it remains elusive whether serum uric acid (SUA) lowering therapy is associated with mortality.